The Experts below are selected from a list of 168 Experts worldwide ranked by ideXlab platform

Sveneric Olsson - One of the best experts on this subject based on the ideXlab platform.

  • effects of a single contraceptive Silastic Implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years
    Fertility and Sterility, 1996
    Co-Authors: Ione Barbosa, Elsimar Coutinho, Cristina Hirsch, Oladapo Ladipo, Sveneric Olsson
    Abstract:

    Objective To study the mechanism of action of Uniplant (South to South Corporation in Reproductive Health, Salvador, Brazil), a single Silastic capsule containing nomegestrol acetate (Lutenyl, Theramex, France) in women during 2 years. Design Comparison between the hormonal levels, follicular development, cervical mucus (CM) production, and endometrial thickness in the menstrual cycle before Implant insertion and at 1, 6, 12, 18, and 24 months after Implant insertion. Participants A total of 15 women of reproductive age were enrolled for the 1st year of use. Twelve of these women continued for a 2nd year of Uniplant use. Main Outcome Measures Hormonal plasma levels were measured in control cycles and at 1, 6, 12, 18, and 24 months of Uniplant use. Cervical mucus, follicular development, and endometrial thickness also were evaluated. Results In this study, Uniplant blocks ovulation in 86% of cycles studied. Disturbances in follicular growth were observed also. Cervical mucus was scanty and viscous in all women during this study. Endometrial thickness was Conclusion This study shows that Uniplant is a long-acting contraceptive that probably acts at the hypothalamic-pituitary levels, on the ovary, on CM production, and on the endometrium. These properties suggest the use of Uniplant as a contraceptive agent, especially if one considers the lack of androgenic and metabolic effects and the maintenance of periodic bleeding similar to menstruation.

Tim Clough - One of the best experts on this subject based on the ideXlab platform.

Santosh Rath - One of the best experts on this subject based on the ideXlab platform.

  • Revision procedures for complications of surgery for osteoarthritis of the carpometacarpal joint of the thumb
    Journal of Hand Surgery (European Volume), 1993
    Co-Authors: W B Conolly, Santosh Rath
    Abstract:

    Abstract Between the years 1980 to 1987, 17 patients had revision procedures for complication s of surgery for osteroarthritis of the carpometacarpal joint of the thumb 12 followed Silastic Implant arthroplasty, four trapeziectomy and one arthrodesis. The failed Silastic arthroplasties were treated by removal of the Implant, and soft tissue arthroplasty in eight, revision with another Implant in three and intermetacarpal bone grafting in one. Patients with metacarpo-scaphoid arthiritis after trapeziectomy were treated by Silastic Implant arthroplasty in three and fusion in one. Nine of the 17 revision procedures (53%) had good, three (18%) fair and five (29%) poor results respectively.

  • Silastic Implant arthroplasty for post traumatic stiffness of the finger joints
    Journal of Hand Surgery (European Volume), 1991
    Co-Authors: W B Conolly, Santosh Rath
    Abstract:

    In the years 1981 to 1987, 50 patients had 59 replacements of the finger joints. Of these, 41 patients with 49 joint operations were reviewed, with follow-up ranging from two to eight years (average 32 months). About 80% of these patients were satisfied that Silastic Implant arthroplasty had relieved their pain and stiffness and improved function of the finger and hand. They were satisfied that this procedure was preferable to amputation or fusion. Success or failure was assessed not only on the range of movement of the joint being replaced, but on relief of pain, correction of deformity, stability and overall finger function. The seven patients regarded as failures are analysed in detail.

Ione Barbosa - One of the best experts on this subject based on the ideXlab platform.

  • effects of a single contraceptive Silastic Implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years
    Fertility and Sterility, 1996
    Co-Authors: Ione Barbosa, Elsimar Coutinho, Cristina Hirsch, Oladapo Ladipo, Sveneric Olsson
    Abstract:

    Objective To study the mechanism of action of Uniplant (South to South Corporation in Reproductive Health, Salvador, Brazil), a single Silastic capsule containing nomegestrol acetate (Lutenyl, Theramex, France) in women during 2 years. Design Comparison between the hormonal levels, follicular development, cervical mucus (CM) production, and endometrial thickness in the menstrual cycle before Implant insertion and at 1, 6, 12, 18, and 24 months after Implant insertion. Participants A total of 15 women of reproductive age were enrolled for the 1st year of use. Twelve of these women continued for a 2nd year of Uniplant use. Main Outcome Measures Hormonal plasma levels were measured in control cycles and at 1, 6, 12, 18, and 24 months of Uniplant use. Cervical mucus, follicular development, and endometrial thickness also were evaluated. Results In this study, Uniplant blocks ovulation in 86% of cycles studied. Disturbances in follicular growth were observed also. Cervical mucus was scanty and viscous in all women during this study. Endometrial thickness was Conclusion This study shows that Uniplant is a long-acting contraceptive that probably acts at the hypothalamic-pituitary levels, on the ovary, on CM production, and on the endometrium. These properties suggest the use of Uniplant as a contraceptive agent, especially if one considers the lack of androgenic and metabolic effects and the maintenance of periodic bleeding similar to menstruation.

Samer S Morgan - One of the best experts on this subject based on the ideXlab platform.